The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.
The Pharmaceutical and Healthcare Association of the Philippines (PHAP) and it's 56 member companies represent the research -based and pharmaceutical and healthcare industry, a key sector in the never ending fight for improved health through the continuous development of new , better, more efficacious and cost-effective drug therapies.
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.
The Philippine Alliance of Patient Organizations (PAPO) is the umbrella organization of all the patient groups in the Philippines. It is an affiliate of the International Alliance of Patient Organizations.
The Philippine Medical Association is the primary medical association of the Philippines, covering medical practitioners and component medical groups from the entire country. It is a member of the World Medical Association and is a co-founder of the Confederation of Medical Associations of Asia and Oceania. It is also the co-founder of Medical Associations of South East Asian Nations.
Fraud Investigation & Dispute Services, Life Sciences
Tighter competition, regulatory scrutiny and tough enforcement heighten the risk of litigation and non-compliance. In your industry, compliance issues and risk factors need to be addressed at every turn, from research and development to marketing strategies and supply chain integrity. And the scrutiny of regulators and customers alike is increasing and rapidly changing.
EY professionals understand the complex issues facing pharmaceutical, biotechnology and medical device companies. We have significant experience helping companies evaluate and manage those aspects of their businesses that pose the greatest potential risks. Our dedicated teams include CPAs, government contract analysts, economists, licensed pharmacists and certified fraud examiners, as well as former pharmaceutical executives, ethics and compliance officers and government auditors, investigators and prosecutors.
For more information visit www.ey.com.
Baker & McKenzie has helped pharmaceuticals and healthcare companies stay ahead in established markets and gain ground in new ones for over 50 years. It is the sole law firm ranked Band 1 in the 2014 and 2015 Chambers Asia Pacific Life Sciences rankings. Our Asia Pacific team consists of more than 180 lawyers who are all part of a global team of 450 lawyers with deep experience in local regulatory processes and laws affecting pharmaceutical, medical device and biotechnology businesses.
Like our clients, we pride ourselves on being innovative. This includes: (i) assembling a team of lawyers who also hold medical-related degrees and have work experience in medical-related fields; (ii) providing customised training, such as our annual training day; (iii) facilitating the sharing of opinions with our annual Life Sciences Roundtable; and (iv) inventing leading tools for clients such as the MapApp--a mobile phone application delivering real-time updates to life sciences clients on smartphones and tablet devices--which was named "Most Innovative in Technology" by the 2015 Financial Times Asia Pacific Innovative Lawyers Awards.
Our group has a legal network spanning 77 locations in 47 countries, including 17 offices across Asia Pacific. The Asia Pacific team consists of lawyers who understand the increasingly pressurized regulatory regimes and competitive markets in which our clients operate. The group also includes non-lawyer medical experts, lawyers who are medical practitioners and lawyers who hold PhDs in medical related fields, ranging from molecular biology, biotechnology or pharmacology to nursing and bioethics. In addition, many of our team are former life sciences professionals or have worked in the industry.
For more information, please visit www.bakermckenzie.com, or contact Ben McLaughlin, Chair of the Asia Pacific Pharmaceuticals & Healthcare Industry Groups, at +61 2 8922 5342.
Through the creation of bespoke solutions for the pharmaceutical, medical device and cosmetic industries, BMI SYSTEM is the leader in providing software solutions dedicated to transparency and regulatory compliance. Beyond BMI SYSTEM's extensive experience in the IT sector, the team possesses in-depth knowledge of the healthcare industry, which allows us to deliver best-of-breed business and technical solutions. For more information visit www.BMI-SYSTEM.com.
Those of us in the Davis Wright Tremaine health care practice group devote nearly all of our time to industry-specific matters. This allows us to develop niche practices within the field that serve needs unique to the health care market. We also understand the business issues and regulatory developments that affect health care delivery and compliance, and as a unified team we can match the attorney with the niche expertise that best addresses client needs. For more information visit our website at www.DWT.com.
Deloitte provides audit, consulting, financial advisory, risk management, tax and related services to public and private clients spanning multiple industries. With a globally connected network of member firms in more than 150 countries and territories, Deloitte brings world-class capabilities and high-quality service to clients, delivering the insights they need to address their most complex business challenges. Deloitte's more than 220,000 professionals are committed to making an impact that matters.
For more information, visit www.deloitte.com/sg.
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. Drawing on information from 100,000 suppliers, and on insights from more than 55 billion healthcare transactions processed annually, IMS Health's approximately 10,000 employees drive results for healthcare clients globally. Customers include pharmaceutical, consumer health and medical device manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community.
IMS Health's industry leading aggregate spend solution, AggregateSpend360, helps pharmaceutical and medical device companies efficiently comply with local, regional and global transparency requirements -- such as the Sunshine Act in the US, the Réforme du Médicament in France, disclosure guided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), and anti-bribery regulations such as the UK Bribery Act and Foreign Corrupt Practices Act. It is a pro-active, web-based application that automates and streamlines the tracking and reporting of all expenditures between Life Sciences companies and healthcare professionals.
For more information, visit www.IMSHealth.com.
Polaris helps Pharmaceutical, Biotech, and Medical Device Companies to be compliant with laws and regulations in- and outside the US. We provide best in class compliance solutions. The world's largest life sciences companies rely on us to achieve their health care compliance goals, to add value to their bottom lines and to always know what's next. With proven global expertise in providing insightful consulting, strategic business process optimization and technology solutions, Polaris is the world's leader in innovative, end-to-end compliance services for life sciences companies. Only Polaris specializes exclusively in consulting and technology solutions for life sciences healthcare law compliance so we are uniquely positioned to assist our customers to increase efficiency, mitigate risk and improve patient safety. For more information visit us at www.polarismanagement.com.
Sidley Austin LLP is a premier law firm with an internationally recognized life sciences practice, representing major pharmaceutical, biotechnology, medical device, diagnostics, dietary supplements and food clients. Sidley consistently ranks among the top firms in Asia, Europe and the U.S. and many lawyers on our team are acknowledged leaders in their field. Sidley was the first international law firm to establish a stand-alone, comprehensive food and drug regulatory practice in China. We were ranked Tier I in Life Sciences in China by Chambers Asia Pacific since the category was launched in 2009. With more 30 years experience and six offices in Asia, our lawyers advise life sciences clients in every aspect of their business operations, including regulatory and compliance, corporate and M&A, FCPA, government enforcement, antitrust and others.
For more information visit www.Sidley.com or contact Chen Yang at 86-10-5905 5600, Lei LI at 86-10-5905 5505 or Yuet Ming Tham at 852-2509 7645.
With approximately 1,700 attorneys in 23 offices on five continents, Skadden represents a broad range of clients in all sectors of the health care industry. We advise pharmaceutical and medical technology clients across the areas of transactions, government regulation and investigation, and litigation. Our work has included multibillion-dollar mergers, complex licensing transactions, product liability defenses, intellectual property matters, and regulatory and enforcement challenges. Skadden has assisted many companies in developing and implementing global anti-bribery and anti-corruption compliance programs, and represented numerous companies in related government investigations.
For more information visit www.skadden.com.